GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $836 | -7.2% | 23,704 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $901 | -2.6% | 23,704 | -3.2% | 0.00% | 0.0% |
| Q1 2023 | $925 | +1.1% | 24,487 | +13.5% | 0.00% | 0.0% |
| Q4 2022 | $915 | -99.9% | 21,581 | -26.1% | 0.00% | -25.0% |
| Q3 2022 | $938,000 | -13.6% | 29,208 | -12.7% | 0.00% | 0.0% |
| Q2 2022 | $1,086,000 | -9.9% | 33,440 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,205,000 | -34.8% | 33,304 | -28.7% | 0.00% | -33.3% |
| Q4 2021 | $1,847,000 | +7.4% | 46,682 | +18.6% | 0.01% | 0.0% |
| Q3 2021 | $1,719,000 | -61.7% | 39,345 | -64.2% | 0.01% | -62.5% |
| Q2 2021 | $4,491,000 | +24.2% | 109,983 | -0.1% | 0.02% | +6.7% |
| Q1 2021 | $3,616,000 | -2.3% | 110,145 | +21.0% | 0.02% | -11.8% |
| Q4 2020 | $3,703,000 | – | 91,062 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |